1. Exercise capacity in axial spondyloarthritis and associated factors: A cross‐sectional controlled study
- Author
-
Gönen Mengi, Nihal Taş, Ebru Köseoğlu Tohma, Ozden Ozyemisci Taskiran, Nesrin Demirsoy, and Zafer Günendi
- Subjects
Adult ,Male ,medicine.medical_specialty ,Time Factors ,Waist ,Turkey ,Risk Assessment ,Metabolic equivalent ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Bruce protocol ,Rheumatology ,Heart Rate ,Internal medicine ,Heart rate ,medicine ,Humans ,Obesity ,030212 general & internal medicine ,Dyslipidemias ,030203 arthritis & rheumatology ,Ankylosing spondylitis ,Exercise Tolerance ,Framingham Risk Score ,Cholesterol ,business.industry ,Middle Aged ,Prognosis ,medicine.disease ,Cross-Sectional Studies ,chemistry ,Cardiovascular Diseases ,Heart Disease Risk Factors ,Case-Control Studies ,Exercise Test ,Female ,business ,Body mass index ,Axial Spondyloarthritis - Abstract
OBJECTIVE To examine the associations between exercise capacity (EC), cardiovascular (CV) risk factors and disease-related variables in axial spondyloarthritis (AxSpA) patients. METHODS In this cross-sectional controlled study, CV risk profile data, physical activity, 10-year CV event risk estimated by the Framingham model and Ankylosing Spondylitis Disease Activity Score - C-reactive protein were recorded. A maximal treadmill exercise test by Bruce protocol was administered. Analyses of covariance were performed with adjustments for age, smoking status and physical activity level. Linear regression analysis was performed to study the association between EC and related CV risk factors. RESULTS Thirty-eight patients and 38 age-gender matched controls were recruited between May and October 2014. Patients had significantly lower EC than controls (MD 2.2; metabolic equivalents 0.91-3.49; P = .001). The difference remained significant after adjustments (P = .001). There were significant correlations between EC and age, 10-year CV event risk, body mass index (BMI) and waist circumference for patients and controls (P
- Published
- 2021
- Full Text
- View/download PDF